We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
+13.38%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.05B
AUM Growth
-$106M
(-9.2%)
Cap. Flow
-$174M
Cap. Flow
% of AUM
-16.63%
Top 10 Holdings %
Top 10 Hldgs %
5.73%
Holding
1,387
New
364
Increased
246
Reduced
349
Closed
422
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
+$5.05M |
| 2 |
Century Aluminum
CENX
|
+$4.6M |
| 3 |
CBM
Cambrex Corporation
CBM
|
+$4.54M |
| 4 |
BBBY
Bed Bath & Beyond
BBBY
|
+$4.51M |
| 5 |
MACK
Merrimack Pharmaceuticals, Inc.
MACK
|
+$4.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OneSpan
OSPN
|
+$7.67M |
| 2 |
Lattice Semiconductor
LSCC
|
+$7.09M |
| 3 |
Mercury Insurance
MCY
|
+$5.38M |
| 4 |
Omnicell
OMCL
|
+$5.15M |
| 5 |
Maximus
MMS
|
+$4.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.11% |
| 2 | Technology | 14.11% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Industrials | 10.88% |
| 5 | Financials | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BKS
51
DELISTED
Barnes & Noble
BKS
| $3.65M | 0.35% |
+239,899
| New | +$3.41M |
|
|
PRSU
52
Pursuit Attractions and Hospitality Inc
PRSU
$1.43B
| $3.64M | 0.35% |
136,698
-9,996
| -7% | -$239K |
|
53
Emergent Biosolutions
EBS
$375M
| $3.63M | 0.35% |
133,355
+90,374
| +210% | +$2.15M |
|
54
Fair Isaac
FICO
$28.7B
| $3.6M | 0.34% |
+49,809
| New | +$3.27M |
|
|
MDAS
55
DELISTED
MEDASSETS INC COM STK (DE)
MDAS
| $3.57M | 0.34% |
180,864
+155,878
| +624% | +$3.17M |
|
56
Telephone and Data Systems
TDS
$3.91B
| $3.55M | 0.34% |
140,751
+88,830
| +171% | +$2.19M |
|
57
Ciena
CIEN
$55.3B
| $3.55M | 0.34% |
+183,019
| New | +$3.06M |
|
58
Group 1 Automotive
GPI
$3.94B
| $3.55M | 0.34% |
+39,566
| New | +$3.32M |
|
59
Andersons Inc
ANDE
$2.65B
| $3.54M | 0.34% |
66,529
+21,620
| +48% | +$1.22M |
|
|
KG
60
Kestrel Group
KG
$71.3M
| $3.51M | 0.34% |
13,737
+4,244
| +45% | +$1.05M |
|
|
PGNX
61
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $3.51M | 0.33% |
463,740
+438,538
| +1,740% | +$2.62M |
|
62
Stepan Co
SCL
$1.31B
| $3.48M | 0.33% |
86,762
+41,879
| +93% | +$1.78M |
|
|
NUVA
63
DELISTED
NuVasive, Inc.
NUVA
| $3.47M | 0.33% |
73,614
-33,789
| -31% | -$1.41M |
|
|
ELX
64
DELISTED
EMULEX CORP
ELX
| $3.47M | 0.33% |
+612,073
| New | +$3.3M |
|
|
VASC
65
DELISTED
Vascular Solutions Inc
VASC
| $3.46M | 0.33% |
127,400
+106,132
| +499% | +$2.88M |
|
|
ENV
66
DELISTED
ENVESTNET, INC.
ENV
| $3.46M | 0.33% |
70,329
-5,282
| -7% | -$248K |
|
67
Supernus Pharmaceuticals
SUPN
$2.68B
| $3.43M | 0.33% |
413,512
+310,997
| +303% | +$2.61M |
|
|
STL
68
DELISTED
Sterling Bancorp
STL
| $3.4M | 0.32% |
+236,059
| New | +$3.2M |
|
69
Nelnet
NNI
$4.79B
| $3.38M | 0.32% |
72,977
+6,509
| +10% | +$296K |
|
|
CKP
70
DELISTED
CHECKPOINT SYSTEMS INC
CKP
| $3.38M | 0.32% |
246,192
+230,778
| +1,497% | +$2.98M |
|
71
Huron Consulting
HURN
$1.82B
| $3.38M | 0.32% |
+49,396
| New | +$3.3M |
|
|
AFFX
72
DELISTED
Affymetrix Inc
AFFX
| $3.36M | 0.32% |
+340,578
| New | +$2.98M |
|
|
EBSB
73
DELISTED
Meridian Bancorp, Inc.
EBSB
| $3.31M | 0.32% |
+295,205
| New | +$3.27M |
|
|
MBFI
74
DELISTED
MB Financial Corp
MBFI
| $3.31M | 0.32% |
100,578
+90,222
| +871% | +$2.75M |
|
|
CAI
75
DELISTED
CAI International, Inc.
CAI
| $3.3M | 0.31% |
142,102
-745
| -0.5% | -$15.8K |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q4 2014 Portfolio in Review
As of Q4 2014, TFS Capital held 1,387 positions worth $1.05B, down 9.2% from $1.15B the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.
TFS Capital withdrew a net $174M in Q4 2014, closing 422 positions and reducing 349 holdings. Its most notable exit was Lattice Semiconductor, an estimated $7.09M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, TFS Capital opened a new position in Infinity Pharmaceuticals, Inc. worth $5.86M.
- TFS Capital's largest Q4 2014 buy was Infinity Pharmaceuticals, Inc.: 347,088 shares worth $5.86M.
- TFS Capital added most to Cambrex Corporation in Q4 2014, an estimated $4.54M increase.
- TFS Capital's biggest Q4 2014 reduction was OneSpan, cutting an estimated $7.67M.
- TFS Capital fully exited Lattice Semiconductor in Q4 2014, selling an estimated $7.09M.
- TFS Capital's ten largest holdings make up 5.7% of its $1.05B portfolio in Q4 2014.
- TFS Capital opened 364 new positions and closed 422 in Q4 2014.
- TFS Capital's portfolio value fell 9.2% quarter-over-quarter to $1.05B.
Based on TFS Capital's 13F filing for Q4 2014, filed 29 Jan 2015.